MabPlex is a leading global CDMO specializing in the development and manufacturing of complex Antibody-Drug Conjugates (ADCs) and biologics. By integrating antibody production, linker-payload synthesis, and site-specific conjugation under one roof, we provide a streamlined “one-stop-shop” for both Drug Substance and Drug Product. Our comprehensive platform offers biologics development, analytical testing, and contract manufacturing services that support the advancement of therapeutic antibodies and ADCs, accelerating the transition from DNA to IND for the next generation of targeted therapies.
With a proven track record of 160+ successful FDA, EMA, and NMPA filings, we help global partners move complex molecules from discovery to the clinic with industry-leading speed and precision.
CLS Member Benefits
Schedule a no-obligation technical consultation or send us a Request for Proposal at [email protected]